Thank you, Howard, and good morning, everyone. I will start by congratulating all our associates for delivering a strong start to the year. As Howard mentioned in his remarks, thanks to our team's efforts in the first quarter, we are well on our way to delivering our 2024 commitments, as well as our 2026 targets introduced at our Investor Day back in December. In the first quarter, our organic net sales increased 1.5%. Adjusted EBITDA increased 7.4%, and adjusted earnings per share increased 27.3% as our productivity programs and actions to optimize our network and portfolio are delivering stronger profitability. Importantly, our organic net sales growth, combined with these actions resulted in our fifth consecutive quarter of adjusted EBITDA margin expansion as we delivered 12.5% adjusted EBITDA margin in the quarter. During the quarter, our organic net sales performance was led by volume mix growth of 1.1%, driven by our Power Four brands. Pricing increased 40 basis points due to certain price pack architecture adjustments to be better positioned in the marketplace, as well as price realization in our partner brands. Finally, our total net sales growth was impacted by the conversion of company-owned RSP routes to independent operators, which reduced growth by 40 basis points and the divestiture of the RW Garcia and Good Health plans, which reduced net sales growth by 2.5%. Moving down the P&L. Adjusted gross margin expanded 280 basis points in the first quarter. I will note that our first quarter margin expansion was better than we had originally anticipated with our productivity programs, driven by manufacturing plant and procurement savings, delivering stronger results, which more than offset inflation and supply chain investments to support our growth. Adjusted SG&A expense increased 6% as productivity within selling and logistics was offset as expected by continued investments in e-commerce, as well as selling capabilities that support our expansion into new geographies. To that end, in the quarter, we had higher-than-expected delivery costs given unplanned Boulder Canyon transfer shipments to support significant volume growth in the East. That said, we are now producing Boulder Canyon potato chips in Hanover to support more profitable growth in this area of the country. Finally, our marketing expense increased 40 basis points as a percent of sales, consistent with our strategy as we invest in capabilities and spend to grow our share of voice in the marketplace. Bringing it together, adjusted EBITDA increased 7.4% to $43.4 million, and margins expanded 100 basis points to 12.5% of sales. The margin expansion was driven by 400 basis points of productivity and 40 basis points of price, partially offset by 220 basis points of supply chain costs, 80 basis points from selling and adding expenses, and 40 basis points from higher market expense. In addition, adjusted net income increased 38.7% and adjusted EPS increased by 27.3% to $0.14 per share. Stronger operating earnings were aided by lower core D&A and lower interest expense. Turning to cash flow and the balance sheet. Consistent with normal seasonality, cash flow used in operations was $9.1 million, and capital expenditures were $13.6 million, primarily related to investments in our manufacturing plants. In addition, we paid $8 million in dividends and distributions to shareholders. Finishing with the balance sheet, cash on hand was $47 million, and our liquidity remained strong at nearly $200 million, giving us ample financial flexibility. Net debt at quarter end was $728 million or 3.8x trailing 12 months normalized adjusted EBITDA of $190.1 million. Just to note, this represents an improvement of 1.3 turns versus the end of the first quarter last year. As a reminder, on February 5, we closed the disposition transactions of the Good Health and RW Garcia brands, and 3 manufacturing facilities. The transaction included a total consideration of $182.5 million, with approximately $150 million in after-tax proceeds, which we immediately used to pay down long-term debt. In addition, after the quarter ended, we closed their dispositions of 2 additional manufacturing facilities and used $9 million in net proceeds to pay down long-term debt and put $5 million on the balance sheet. We have also successfully completed a repricing of our $630 million term loan due in January 2028, which reduced the applicable interest rate by 36 basis points. These 2 debt repayments plus the lower interest rate on our term loan will result in approximately $40 million in lower interest expense for 2024. Notably, our fixed rate debt now comprises approximately 80% of our total debt. Consistent with our strategy, these actions accelerate our time frame to achieving our target of 3x net leverage ratio to year-end 2025, which, as you know, is a year ahead from year-end 2026 target set at Investor Day in December. Now, turning to our full year outlook for fiscal 2024. Our 2024 outlook continues to position us well to deliver our 2026 financial targets. We are maintaining our organic net sales outlook for growth of approximately 3% or better, which reflects our outlook for normalizing salty snack category growth and our growth rate accelerating largely led by distribution gains. Our growth is expected to be led by volume with outsized strength in our expansion geographies and pricing about flat for the year. In terms of phasing, we continue to expect about a 49-51 first half, second half split for our net sales. Moving to adjusted EBITDA. We continue to expect growth of 5% to 8%, fueled by gross margin expansion from our productivity program, partially offset by investments in growth. Our first quarter productivity benefit was higher than expected, which gives us confidence in our ability to deliver on our cost savings commitments this year and now expand adjusted gross margins more than the 200 basis points that was previously assumed in our guidance. That said, we will step up investments in our growth as gross margin expansion come through to find investments to support distribution gains, particularly in our expansion geographies, as well as investments in marketing and capability. Our 2024 adjusted EBITDA outlook continues to maintain a balance between productivity savings and investments. Finally, we are raising our adjusted earnings per share growth to 23% to 28%, given our revised expectation for a more favorable effective tax rate, and also lower interest expense after factoring in the use of net proceeds to pay down long-term debt from our April 2024 manufacturing plant disposition, and the favorable repricing of our term loan. We now expect our adjusted effective tax rate to be between 18% to 20%, and interest expense of approximately $47 million. Our outlook for capital investments of between $80 million to $90 million is unchanged, as is our net leverage outlook of approximately 3.6x at fiscal year-end 2024, which I'll note is a full turn improvement from year-end 2023. Our 2024 outlook and improved capital structure and building momentum in our productivity program, as well as capabilities that allow us to invest in growth, position us well to deliver our 3-year goals. More importantly, I'm excited to see the entire Utz team working together to deliver on our 4 fundamental strategies. Operator, we would now like to open up the call for questions.